Scheduling delegate's final decisions, July 2016
Scheduling medicines and poisons
Summary of delegate's final decisions
Part A - Final decisions on matters referred to an expert advisory committee
2. Scheduling proposals referred to the July 2016 meeting of the Advisory Committee on Chemicals Scheduling (ACCS#17)
| Substance | Final decision |
|---|---|
| Direct Red 254 |
Schedule 6 - New EntryDIRECT RED 254 except when included in Schedule 5. Schedule 5 - New EntryDIRECT RED 254 in preparations containing 30 per cent or less of Direct Red 254. Index - New EntryDIRECT RED 254 cross reference: 2-NAPHTHALENESULFONIC ACID, 7-AMINO-4-HYDROXY-3-[[P-[(P-SULFOPHENYL)AZO]PHENYL]AZO]-, BIS(TRIETHANOLAMINE) SALT Schedule 5 Schedule 6 Implementation date: 1 February 2017 |
| Aminopyralid |
Schedule 6 - Current EntryAMINOPYRALID except when included in Schedule 5. Schedule 5 - Amend EntryAMINOPYRALID in preparations containing 22 per cent or less of aminopyralid. Implementation date: 1 February 2017 |
| Metazachlor |
Schedule 5 − New EntryMETAZACHLOR. Implementation date: 1 February 2017 |
| Quinoline |
Schedule 6 - New EntryQUINOLINE and its salts (excluding other derivatives). Index - New EntryQUINOLINE. cross reference: 2,3-BENZAPYRIDINE Schedule 6 Appendix E, Part 2 Appendix F, Part 3 Appendix E - QUINOLINE Standard statements: A [for advice, contact a Poisons Information Centre (e.g. phone Australia 13 11 26; New Zealand 0800 764 766) or a doctor (at once)], E1 (if in eyes wash out immediately with water), S1 (if skin or hair contact occurs, remove contaminated clothing and flush skin and hair with running water). Appendix F - QUINOLINE Warning Statement: 79 (will irritate eyes). Safety Directions: 1 (avoid contact with eyes), 4 (avoid contact with skin). Implementation date: 1 February 2017 |
| Phenoxymethyl oxirane |
Schedule 6 - New EntryPHENOXYMETHYL OXIRANE. Appendix E - PHENOXYMETHYL OXIRANE Standard Statements: A [for advice, contact a Poisons Information Centre (e.g. phone Australia 13 11 26; New Zealand 0800 764 766) or a doctor (at once)], E1 (if in eyes wash out immediately with water). Appendix F - PHENOXYMETHYL OXIRANE Warning Statements: 12 (vapour is harmful to health on prolonged exposure), 28 [(Over) (Repeated) exposure may cause sensitisation], 51 (irritant to skin, eyes, mucous membranes and upper respiratory tract). Safety Directions: 1 (avoid contact with eyes), 3 (wear eye protection when mixing or using), 4 (avoid contact with skin), 5 (wear protective gloves when mixing or using), 7 (wash hands thoroughly after use), 8 (avoid breathing vapour), 9 (use only when in well-ventilated areas). Implementation date: 1 February 2017 |
| n-Hexane | The current scheduling remains appropriate for n-hexane. |
| Amyl and hexyl cinnamaldehyde |
Appendix B - New EntriesAMYL CINNAMALDEHYDE HEXYL CINNAMALDEHYDE Implementation date: 1 February 2017 |
| Isoeugenol |
Schedule 6 - Amend EntryISOEUGENOL except:
Schedule 5 - Amend EntryISOEUGENOL in preparations not intended for skin contact containing 25 per cent or less of isoeugenol except in preparations intended for contact with skin containing 0.5 per cent or less of isoeugenol. Implementation date: 1 June 2017 |